CBU
MIRM icon

CIBC Bancorp USA’s Mirum Pharmaceuticals MIRM Stock Holding History

CIBC Bancorp USA’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
+2,623
New +$263K ﹤0.01% 1521
2025
Q3 		$315K Buy
+4,303
New +$274K ﹤0.01% 1059

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Bancorp USA's MIRM Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 2,623 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in MIRM as recently as Q3 2025.

CIBC Bancorp USA first reported a position in MIRM in Q3 2025 and has held it in 2 quarters since. The position peaked at $315K in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • CIBC Bancorp USA held 2,623 shares of Mirum Pharmaceuticals worth $307K as of Q2 2026.
  • Mirum Pharmaceuticals was a new CIBC Bancorp USA position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1521 holding.
  • CIBC Bancorp USA first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Mirum Pharmaceuticals position peaked at $315K in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.